A detailed history of Tfb Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Tfb Advisors LLC holds 4,098 shares of AMGN stock, worth $1.29 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
4,098
Previous 3,643 12.49%
Holding current value
$1.29 Million
Previous $1.04 Million 23.67%
% of portfolio
0.42%
Previous 0.36%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $119,551 - $145,286
455 Added 12.49%
4,098 $1.28 Million
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $355,177 - $428,743
1,321 Added 56.89%
3,643 $1.04 Million
Q4 2023

Jan 18, 2024

BUY
$255.7 - $288.46 $593,735 - $669,804
2,322 New
2,322 $668,000
Q2 2023

Jul 18, 2023

BUY
$214.27 - $253.37 $346,688 - $409,952
1,618 Added 114.18%
3,035 $673,000
Q1 2023

Apr 10, 2023

BUY
$225.79 - $275.2 $3,386 - $4,128
15 Added 1.07%
1,417 $342,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $321,100 - $407,996
1,402 New
1,402 $368,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tfb Advisors LLC Portfolio

Follow Tfb Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfb Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfb Advisors LLC with notifications on news.